1350P Immuno-chemotherapy alone for laryngeal cancer: ICoLP phase II trial with >2-year follow-up.

Saved in:
Bibliographic Details
Title: 1350P Immuno-chemotherapy alone for laryngeal cancer: ICoLP phase II trial with >2-year follow-up.
Authors: Ferrarotto, R.1 (AUTHOR), Hutcheson, K.2 (AUTHOR), Sui, D.3 (AUTHOR), Johnson, F.4 (AUTHOR), Ebersole, B.5 (AUTHOR), Johnson, J.M.6 (AUTHOR), Lewis, C.7 (AUTHOR), Cunha, M.T.8 (AUTHOR), Williams, M.9 (AUTHOR), Gunn, B.10 (AUTHOR), Myers, J.7 (AUTHOR), Lee, J.J.3 (AUTHOR), Rosenthal, D.11 (AUTHOR), Diaz, E.12 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS840-S841. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2025.08.1982